We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Specific Leukocyte Count Predicts Bacteremia

By LabMedica International staff writers
Posted on 24 Nov 2010
A decrease in the absolute number of lymphocytes in a white blood cell (WBC) count is thought to be an indicator that the patient may have a bacterial infection in the blood. More...


Similarly, the neutrophil-lymphocyte count ratio (NLCR) has been shown as a simple promising method to evaluate systemic inflammation in critically ill patients. These two parameters may be better than conventional infection markers in an emergency care unit.

In a retrospective study carried out at the emergency department (ED) of the Jeroen Bosch Hospital, (Hertogenbosch; The Netherlands) examined consecutive patient records from adult patients (18 years or older) admitted to the ED over a seven month period from April to October 2005, with suspected community-acquired bacteremia. C-reactive protein (CRP) level, WBC count, neutrophil count, lymphocyte count, and NLCR were compared between 92 patients with positive blood cultures and an equal number of age and gender matched patients with negative blood cultures.

CRP levels were measured with a fully automated enzyme-linked immunoassay using an Aeroset 2.0 analyzer (Abbott Diagnostics; Santa Clara, CA, USA). WBC, neutrophil and lymphocyte counts were determined on a Sysmex XE-2100 hematology analyzer (Sysmex Corporation; Kobe, Japan). Significant differences between patients with positive and negative blood cultures were detected with respect to CRP level (176 ± 138 mg/L versus 116 ± 103 mg/L; lymphocyte count (0.8 ± 0.5 × 109/L versus 1.2 ± 0.7 × 109/L; and NLCR (20.9 ± 13.3 versus 13.2 ± 14.1). However, there were no significant differences regarding WBC count and neutrophil count. Sensitivity, specificity, positive and negative predictive values were highest for the NLCR (77.2%, 63.0%, 67.6% and 73.4%, respectively).

Culturing microorganisms is the most definitive way to confirm bacterial infections. Unfortunately, this gold standard is time consuming and may be influenced by several factors including previous antibiotic usage. The authors concluded that, "Absolute lymphocytopenia can be used in the prediction of infectious emergency admissions. Moreover, the ratio of neutrophil and lymphocyte counts (NLCR) has even higher value in predicting bacteremia. This marker is simple, easily obtained and calculated, easy to integrate in daily practice and without extra costs.” The study was published on October 29, 2010, in the journal Critical Care.

Related Links:

Jeroen Bosch Hospital
Abbott Diagnostics
Sysmex Corporation




Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Automatic Western Blot Analyzer
Tenfly Phoenix Blot Analyzer
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.